We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

92 hedge funds and large institutions have $745M invested in Tempest Therapeutics in 2015 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

341% more call options, than puts

Call options by funds: $35.9M | Put options by funds: $8.15M

169% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 16

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

7% more funds holding

Funds holding: 86 → 92 (+6)

6% less capital invested

Capital invested by funds: $796M → $745M (-$51.6M)

Holders
92
Holders Change
+6
Holders Change %
+6.98%
% of All Funds
2.48%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
22
Increased
43
Reduced
16
Closed
16
Calls
$35.9M
Puts
$8.15M
Net Calls
+$27.8M
Net Calls Change
+$19.6M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$24.5M
2
GTP
Global Thematic Partners
New York
+$17.2M
3
JHIU
Janus Henderson Investors US
Colorado
+$17.1M
4
OH
Orbis Holdings
Bermuda
+$11.4M
5
State Street
State Street
Massachusetts
+$8.15M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$53.9M
2
DM
Deerfield Management
New York
-$14.1M
3
Morgan Stanley
Morgan Stanley
New York
-$7.51M
4
CAM
Cormorant Asset Management
Massachusetts
-$6.6M
5
KCM
Kingdon Capital Management
New York
-$3.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$4.72M +$1.37M +15 +37%
CCA
27
Catalyst Capital Advisors
New York
$4.46M +$1.56M +17 +47%
GIM
28
Granahan Investment Management
Massachusetts
$3.92M -$183K -2 -4%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$3.61M -$183K -2 -4%
ACH
30
ArrowMark Colorado Holdings
Colorado
$3.36M +$1.1M +12 +43%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.35M +$1.19M +13 +48%
Deutsche Bank
32
Deutsche Bank
Germany
$3.13M +$3.39M +37 New
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$3.1M +$2.66M +29 +363%
BIM
34
BlackRock Investment Management
Delaware
$2.42M +$916K +10 +53%
TCIM
35
TIAA CREF Investment Management
New York
$2.31M +$275K +3 +13%
CS
36
Credit Suisse
Switzerland
$2.23M +$275K +3 +13%
Millennium Management
37
Millennium Management
New York
$1.99M +$2.2M +24 New
AIC
38
AWM Investment Company
New York
$1.74M +$1.65M +18 +600%
Invesco
39
Invesco
Georgia
$1.73M -$458K -5 -20%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.72M +$366K +4 +25%
EMFAT
41
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.42M +$1.56M +17 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$1.28M +$733K +8 +114%
GCP
43
GSA Capital Partners
United Kingdom
$1.24M +$366K +4 +36%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.24M +$366K +4 +36%
AQR Capital Management
45
AQR Capital Management
Connecticut
$1.16M +$366K +4 +40%
RFC
46
Russell Frank Company
Washington
$1.16M +$1.28M +14 New
Charles Schwab
47
Charles Schwab
California
$1.12M +$275K +3 +30%
TA
48
Teachers Advisors
New York
$991K +$275K +3 +33%
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
$976K -$91.6K -1 -8%
Group One Trading
50
Group One Trading
Illinois
$945K +$916K +10 +1,000%
1
2
3 4 5

TPST Hedge Fund Activity: Q2 2015 in Review

92 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2015, worth a combined $745M — down 6.5% from $796M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TPST positions and 16 closed out — a net gain of 6 holders — while 43 added to existing stakes and 16 trimmed.

The largest buyer was Jennison Associates, adding an estimated $24.5M. The largest seller was Sabby Management, cutting an estimated $53.9M.

  • 92 institutional investors held Tempest Therapeutics (TPST) as of Q2 2015, up from 86 in Q1 2015.
  • Funds reported $745M of Tempest Therapeutics stock for Q2 2015, down 6.5% quarter-over-quarter.
  • 22 funds opened new Tempest Therapeutics positions in Q2 2015 and 16 closed out, a net change of +6 holders.
  • The largest Tempest Therapeutics buyer in Q2 2015 was Jennison Associates, an estimated $24.5M added.
  • The largest Tempest Therapeutics seller in Q2 2015 was Sabby Management, an estimated $53.9M sold.

Based on aggregated 13F filings for Q2 2015.